A preclinical systematic review and meta-analysis assessing the impact of pharmacological targeting of PPARs in experimental renal injury is underway (105), and may help to inform the design of future studies evaluating PPARα-mediated restoration of FAO in DKD. This evidence concerns the gene PPARA and diabetic kidney disease.